Drug intelligence / Profile preview

butylated hydroxyanisole

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Butylated hydroxyanisole (BHA) is a synthetic phenolic antioxidant composed of a mixture of two isomers, 3-tert-butyl-4-hydroxyanisole and 2-tert-butyl-4-hydroxyanisole. It is widely employed as a preservative in food, food packaging, animal feed, cosmetics, and as an excipient in pharmaceuticals to prevent oxidative degradation and extend shelf life. Its primary mechanism involves scavenging free radicals and activating the Nrf2 signaling pathway, enhancing cellular antioxidant defenses. While classified as "generally recognized as safe" (GRAS) by the FDA within regulated limits, it is also listed as "reasonably anticipated to be a human carcinogen" by the National Toxicology Program based on high-dose animal studies, and concerns exist regarding its potential for endocrine disruption and reproductive toxicity.

Brand names
Tenox BHASustane 1-FSustane1-FSustane-1-FEmbanoxNipantiox 1-FNipantiox1-FNipantiox-1-FProtexAntioxine B
Other names
2-tert-butyl-4-hydroxyanisole and 3-tert-butyl-4-hydroxyanisole (mixture)tert-butyl-4-methoxyphenoltert-butyl4-methoxyphenoltert-butyl 4-methoxyphenol(1,1-Dimethylethyl)-4-methoxyphenoltert-butyl-p-methoxyphenolt-butyl hydroxyanisolemono-tert-butyl-4-hydroxyanisolemono-tert-butyl4-hydroxyanisolemono-tert-butyl 4-hydroxyanisolebutylhydroxyanisole
02

Targets

GST (Glutathione S-transferase alpha 3)

Beyond the preview

Go deeper on butylated hydroxyanisole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on butylated hydroxyanisole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call